Table 2:
Cumulative Incidence of Clinical and/or Biochemical Failure, Biochemical Failure, Local Failure, Distant Metastasis Failure, Other-Cause Mortality, Prostate Cancer-Specific Mortality, and Overall Survival Hazard Ratios by Treatment Arm
| Outcome Type | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical and/or Biochemical Failure |
Biochemical Failure | Local Failure | Distant Metastatic Failure |
Other-Cause Mortality | Prostate Cancer- Specific Mortality |
Overall Survival | |||||||||||||||
| 15- Year (%) |
Univariate | 15- Year (%) |
Univariate | 15- Year (%) |
Univariate | 15- Year (%) |
Univariate | 15- Year (%) |
Univariate | 15- Year (%) |
Univariate | 15- Year (%) |
Univariate | ||||||||
| sHR (95 % CI) |
P- value |
sHR (95 % CI) |
P- value |
sHR (95 % CI) |
P- value |
sHR (95% CI) |
P- value |
sHR (95% CI) |
P- value |
sHR (95 % CI) |
P- value |
HR (95 % CI) |
P- value |
||||||||
| 70-Gy Arm | 18.9 | 1 [Ref] | 0.042 | 12.3 | 1 [Ref] | 0.051 | 11.3 | 1 [Ref] | 0.326 | 3.4 | 1 [Ref] | 0.018 | 45.7 | 1 [Ref] | 0.061 | 6.2 | 1 [Ref] | 0.045 | 53.4 | 1 [Ref] | 0.469 |
| 78-Gy arm | 12.0 | 0.61 (0.38-0.98) | 7.1 | 0.56 (0.31-1.00) | 8.4 | 0.72 (0.39-1.37) | 1.1 | 0.33 (0.13-0.82) | 55.6 | 1.33 (0.99-1.79) | 3.2 | 0.52 (0.27-0.98) | 48.9 | 1.10 (0.84-1.45) | |||||||
Subhazard ratio (sHR); Hazard ratio (HR); confidence interval (CI); Gray (Gy); Reference (Ref)